VIM and endometrioid tumor: Patients with complete loss of vimentin expression in epithelial cells had significantly worse recurrence-free survival compared to patients with vimentin positive tumors in the FIGO I endometrioid tumors (Log rank p < 0.001; Fig. 8b).